Performance of Current Guidelines for Diagnosis of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: To compare the capacity of the 2004 diagnostic guidelines for hemophagocytic lymphohistiocytosis (HLH‐2004) with the capacity of the preliminary diagnostic guidelines for systemic juvenile idiopathic arthritis (JIA)–associated macrophage activation syndrome (MAS) to discriminate MAS complicating systemic JIA from 2 potentially confusable conditions, represented by active systemic JIA without MAS and systemic infection. Methods: International pediatric rheumatologists and hemato‐oncologists were asked to retrospectively collect clinical information from patients with systemic JIA–associated MAS and confusable conditions. The ability of the guidelines to differentiate MAS from the control diseases was evaluated by calculating the sensitivity and specificity of each set of guidelines and the kappa statistics for concordance with the physician's diagnosis. Owing to the fact that not all patients were assessed for hemophagocytosis on bone marrow aspirates and given the lack of data on natural killer cell activity and soluble CD25 levels, the HLH‐2004 guidelines were adapted to enable the diagnosis of MAS when 3 of 5 of the remaining items (3/5‐adapted) or 4 of 5 of the remaining items (4/5‐adapted) were present. Results: The study sample included 362 patients with systemic JIA and MAS, 404 patients with active systemic JIA without MAS, and 345 patients with systemic infection. The best capacity to differentiate MAS from systemic JIA without MAS was found when the preliminary MAS guidelines were applied. The 3/5‐adapted HLH‐2004 guidelines performed better than the 4/5‐adapted guidelines in distinguishing MAS from active systemic JIA without MAS. The 3/5‐adapted HLH‐2004 guidelines and the preliminary MAS guidelines with the addition of ferritin levels ≥500 ng/ml discriminated best between MAS and systemic infections. Conclusion: The preliminary MAS guidelines showed the strongest ability to identify MAS in systemic JIA. The addition of hyperferritinemia enhanced their capacity to differentiate MAS from systemic infections. The HLH‐2004 guidelines are likely not appropriate for identification of MAS in children with systemic JIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529786 · Cited by 4,332
The diagnostic odds ratio: a single indicator of test performance
Glas, A. S., Lijmer, J. G., Prins, M. H., Bonsel, G. J., & Bossuyt, P. M. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00177-x · Cited by 2,261 · cited 1×
“The DOR of a test is the ratio of the odds of positivity in subjects with the disease to the odds of positivity in subjects without the disease; the value of the DOR ranges from 0 to infinity, with higher values indicating better performance of a discriminatory test (22).”
BackgroundRepeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice
Behrens, E. M., Canna, S. W., Slade, K., Rao, S., Kreiger, P. A., Paessler, M., Kambayashi, T., & Koretzky, G. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43157 · Cited by 392 · cited 1×
“The presence of hemophagocytosis may be governed by a relative paucity of the antiinflammatory cytokine interleukin-10 (IL-10) (7).”
BackgroundBleesing, J., Prada, A., Siegel, D. M., Villanueva, J., Olson, J., Ilowite, N. T., Brunner, H. I., Griffin, T., Graham, T. B., Sherry, D. D., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22416 · Cited by 321 · cited 1×
“However, recent evidence suggests that the syndrome may occur subclinically in an additional 30–40% of systemic JIA patients (8,9).”
BackgroundSelf-citation
Cited by
Ravelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avcin, T., Behrens, E. M., De Benedetti, F., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39332 · Cited by 773
Self-citationHyperferritinemia and inflammation
Kernan, K. F., & Carcillo, J. A. (2017) · International Immunology · doi:10.1093/intimm/dxx031 · Cited by 638
Nakra, N., Blumberg, D., Herrera-Guerra, A., & Lakshminrusimha, S. (2020) · Children · doi:10.3390/children7070069 · Cited by 512
Minoia, F., Davì, S., Horne, A., Demirkaya, E., Bovis, F., Li, C., Lehmberg, K., Weitzman, S., Insalaco, A., Wouters, C., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38802 · Cited by 429
Self-citationRavelli, A., Minoia, F., Davì, S., Horne, A., Bovis, F., Pistorio, A., Aricò, M., Avcin, T., Behrens, E. M., De Benedetti, F., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208982 · Cited by 410
Self-citationBenefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
Eloseily, E. M., Weiser, P., Crayne, C. B., Haines, H., Mannion, M. L., Stoll, M. L., Beukelman, T., Atkinson, T. P., & Cron, R. Q. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41103 · Cited by 282
“Other studies have reported hemophagocytosis in 64% (44) to 84% (45) of patients with secondary HLH/MAS who had a bone marrow aspirate assessed or a reticuloendothelial organ biopsy performed.”
BackgroundSelf-citationSchulert, G. S., Zhang, M., Fall, N., Husami, A., Kissell, D., Hanosh, A., Zhang, K., Davis, K., Jentzen, J. M., Napolitano, L., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv550 · Cited by 170
“these criteria was 100% specific but only 35% sensitive for the diagnosis of MAS [43].”
BackgroundSelf-citationSystemic Juvenile Idiopathic Arthritis
Lee, J. J. Y., & Schneider, R. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.04.005 · Cited by 166
Metadata
- Authors
- Davì, S., Minoia, F., Pistorio, A., Horne, A., Consolaro, A., Rosina, S., Bovis, F., Cimaz, R., Gamir, M. L., Ilowite, N. T., Kone‐Paut, I., Feitosa de Oliveira, S. K., McCurdy, D., Silva, C. A., Sztajnbok, F., Tsitsami, E., Unsal, E., Weiss, J. E., Wulffraat, N., Abinun, M., Aggarwal, A., Apaz, M. T., Astigarraga, I., Corona, F., Cuttica, R., D'Angelo, G., Eisenstein, E. M., Hashad, S., Lepore, L., Mulaosmanovic, V., Nielsen, S., Prahalad, S., Rigante, D., Stanevicha, V., Sterba, G., Susic, G., Takei, S., Trauzeddel, R., Zletni, M., Ruperto, N., Martini, A., Cron, R. Q., Ravelli, A., & on behalf of the Paediatric Rheumatology International Trials Organisation, T. C. A. A. R. R. A.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2014-09-26
- Volume
- 66
- Issue
- 10
- Pages
- 2871-2880
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W1530448872
- Cited by
- 117
- References
- 4
- FWCI
- 10.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.